On the Record · Insulet
Insulet acquisitions, on the record
The businesses Insulet bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Dynalloy, Inc.Word for word“In 2022, we paid $26.0 million to acquire substantially all the assets related to the manufacture and production of shape-memory alloy wire assemblies that are used in the production of Pods from Dynalloy, Inc.” 10-K for 2023 | acquisition | 2022 | $26.0 million |
patent assets related to pump-based automated insulin delivery technologies from Bigfoot Biomedical, Inc.Word for word“In February 2023, the Company paid Bigfoot Biomedical, Inc. $ 25.1 million, including transaction costs, to acquire patent assets related to pump-based automated insulin delivery technologies.” 10-K for 2024 | acquisition | February 2023 | $ 25.1 million |
Automated Glucose Control LLCWord for word“Pursuant to the Asset Purchase Agreement, the Company made a one-time payment of $ 25.0 million for the acquisition of developed technology and patents and the release of future obligations, including any future royalty obligations.” 10-K for 2024 | acquisition | — | $ 25.0 million |
one of our suppliersWord for word“For example, in 2022, we acquired one of our suppliers.” 10-K for 2024 | acquisition | in 2022 | — |
| Fiscal year ended | Goodwill from acquisitions |
|---|---|
| 2016-12-31 | $0 |
| 2022-12-31 | $12 million |
| 2023-12-31 | $0 |
Deal filings since 2016
- 2026-09-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2026-02-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-06-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-03-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-03-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-08-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-05-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-01-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-06-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-06-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-02-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-12-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-06-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-05-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-09-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-07-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-05-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-12-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-12-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-09-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-09-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-08-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Insulet’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.